BioSig Technologies Analyst Ratings
Ascendiant Capital Maintains Buy on BioSig Technologies, Raises Price Target to $2.75
Ascendiant Reaffirms Their Buy Rating on BioSig Technologies (BSGM)
BioSig Technologies Analyst Ratings
Ascendiant Capital Initiates Coverage On BioSig Technologies With Buy Rating, Announces Price Target of $5
BioSig Technologies (BSGM) Gets a Buy From Noble Financial
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Resmed (RMD) and BioSig Technologies (BSGM)
Analysts Offer Insights on Healthcare Companies: BioSig Technologies (BSGM) and Siemens Healthineers AG (OtherSEMHF)